Mesoblast Stock Price on November 21, 2024
| MESO Stock | USD 10.11 0.07 0.69% |
If you're considering investing in Mesoblast Stock, it is important to understand the factors that can impact its price. As of today, the current price of Mesoblast stands at 10.11, as last reported on the 25th of November, with the highest price reaching 10.27 and the lowest price hitting 9.89 during the day. Mesoblast appears to be slightly risky, given 3 months investment horizon. Mesoblast has Sharpe Ratio of 0.17, which conveys that the firm had a 0.17% return per unit of risk over the last 3 months. By analyzing Mesoblast's technical indicators, you can evaluate if the expected return of 0.85% is justified by implied risk. Please exercise Mesoblast's Risk Adjusted Performance of 0.1384, mean deviation of 3.82, and Downside Deviation of 3.94 to check out if our risk estimates are consistent with your expectations.
Mesoblast Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Mesoblast |
Sharpe Ratio = 0.1694
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MESO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.0 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.85 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Mesoblast is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mesoblast by adding it to a well-diversified portfolio.
Related Headline
Eledon Pharmaceuticals Headline on 21st of November 2024
Acquisition by Gros David-alexandre C of 1015743 shares of E... by MacroaxisInsider
Filed transaction by Eledon Pharmaceuticals Director, Officer: Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Mesoblast Valuation on November 21, 2024
It is possible to determine the worth of Mesoblast on a given historical date. On November 21, 2024 Mesoblast was worth 10.05 at the beginning of the trading date compared to the closed value of 10.18. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Mesoblast stock. Still, in general, we apply an absolute valuation method to find Mesoblast's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mesoblast where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Mesoblast's related companies.
| Open | High | Low | Close | Volume | |
| 10.48 | 10.49 | 10.08 | 10.33 | 215,540 | |
11/21/2024 | 10.05 | 10.25 | 9.99 | 10.18 | 231,660 |
| 9.90 | 10.27 | 9.89 | 10.11 | 243,315 |
| Backtest Mesoblast | | | Mesoblast History | | | Mesoblast Valuation | Previous | Next |
Mesoblast Trading Date Momentum on November 21, 2024
| On November 22 2024 Mesoblast was traded for 10.11 at the closing time. The top price for the day was 10.27 and the lowest listed price was 9.89 . The trading volume for the day was 243.3 K. The trading history from November 22, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.69% . The trading delta at closing time against the current closing price is 2.75% . |
Mesoblast Fundamentals Correlations and Trends
By evaluating Mesoblast's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Mesoblast's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Mesoblast financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Mesoblast Stock history
Mesoblast investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mesoblast is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mesoblast will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mesoblast stock prices may prove useful in developing a viable investing in Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, the United Kingdom, and Switzerland. Mesoblast Limited was incorporated in 2004 and is headquartered in Melbourne, Australia. Mesoblast operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 77 people.
Mesoblast Stock Technical Analysis
Mesoblast technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Mesoblast Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Mesoblast cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Mesoblast November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Mesoblast stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mesoblast shares will generate the highest return on investment. By undertsting and applying Mesoblast stock market strength indicators, traders can identify Mesoblast entry and exit signals to maximize returns
Mesoblast Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mesoblast's price direction in advance. Along with the technical and fundamental analysis of Mesoblast Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mesoblast to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1384 | |||
| Jensen Alpha | 0.8617 | |||
| Total Risk Alpha | 0.0495 | |||
| Sortino Ratio | 0.1819 | |||
| Treynor Ratio | (4.05) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.